Treatment guidelines exist for pulmonary Mycobacterium avium complex (MAC) infection, although studies suggest poor concordance in clinician practice. Using a national database including hospital encounters of laboratory-confirmed MAC patients, we sought to characterise US treatment practices. We assessed patients in the Premier Healthcare Database from 2009 to 2013 with two or more MAC-positive cultures or one MAC-positive culture and the International Classification of Diseases (9th revision) code for pulmonary nontuberculous mycobacteria (PNTM). Treatment was characterised by patient-, provider- and facility-level factors; significant differences were assessed (p<0.05). Multilevel Poisson regression estimated adjusted relative risks (aRR...
BackgroundCommunity-acquired pneumonia (CAP) 2007 guidelines from the Infectious Diseases Society of...
Background: Only a few clinical factors can aid in predicting spontaneous culture conversion (SCC) i...
Treatment of Mycobacterium abscessus pulmonary disease (MAB-PD), caused by M. abscessus subsp. absce...
Surveys suggest that clinicians diverge from guidelines when treating Mycobacterium avium complex (M...
Introduction The burden of Mycobacterium avium complex (MAC) lung disease is increasing globally and...
BackgroundAlthough combination therapy using clarithromycin, rifampicin, and ethambutol is recommend...
Summary: The activity of atypical or non tuberculous mycobacteria (NTM) as pulmonary pathogens has b...
Nontuberculous mycobacterial (NTM) infections present a treatment challenge for clinicians and patie...
Background: The prevalence of nontuberculous mycobacterial lung disease (NTMLD) in the US has increa...
Rationale: The 2016 guidelines for hospital-acquired pneumonia (HAP) suggest applying a universal an...
Item does not contain fulltextRationale: Currently recommended multidrug treatment regimens for Myco...
BACKGROUND: Macrolide is a key drug in the treatment of Mycobacterium avium complex pulmonary dise...
Introduction/Aim: Mycobacterium avium complex pulmonary disease (MAC‐PD) rates are increasing worldw...
empirical treatment of severe CAP (Table 1). This is defined as the presence of signs and symptoms o...
Pneumonia is a threat to all States. CAP treatment in hospitals typically uses empirical antibiotic ...
BackgroundCommunity-acquired pneumonia (CAP) 2007 guidelines from the Infectious Diseases Society of...
Background: Only a few clinical factors can aid in predicting spontaneous culture conversion (SCC) i...
Treatment of Mycobacterium abscessus pulmonary disease (MAB-PD), caused by M. abscessus subsp. absce...
Surveys suggest that clinicians diverge from guidelines when treating Mycobacterium avium complex (M...
Introduction The burden of Mycobacterium avium complex (MAC) lung disease is increasing globally and...
BackgroundAlthough combination therapy using clarithromycin, rifampicin, and ethambutol is recommend...
Summary: The activity of atypical or non tuberculous mycobacteria (NTM) as pulmonary pathogens has b...
Nontuberculous mycobacterial (NTM) infections present a treatment challenge for clinicians and patie...
Background: The prevalence of nontuberculous mycobacterial lung disease (NTMLD) in the US has increa...
Rationale: The 2016 guidelines for hospital-acquired pneumonia (HAP) suggest applying a universal an...
Item does not contain fulltextRationale: Currently recommended multidrug treatment regimens for Myco...
BACKGROUND: Macrolide is a key drug in the treatment of Mycobacterium avium complex pulmonary dise...
Introduction/Aim: Mycobacterium avium complex pulmonary disease (MAC‐PD) rates are increasing worldw...
empirical treatment of severe CAP (Table 1). This is defined as the presence of signs and symptoms o...
Pneumonia is a threat to all States. CAP treatment in hospitals typically uses empirical antibiotic ...
BackgroundCommunity-acquired pneumonia (CAP) 2007 guidelines from the Infectious Diseases Society of...
Background: Only a few clinical factors can aid in predicting spontaneous culture conversion (SCC) i...
Treatment of Mycobacterium abscessus pulmonary disease (MAB-PD), caused by M. abscessus subsp. absce...